Table 1. Characteristics of Participants at ARIC Study Visit 4 According to Past Change in NT-proBNP.
Characteristic | Mean (SD)a | P value | ||||
---|---|---|---|---|---|---|
Total (N = 9776) | Visit 2 <125 pg/mL | Visit 2 ≥125 pg/mL | ||||
Visit 4 <125 pg/mL (n = 6693) | Visit 4 ≥125 pg/mL (n = 1744) | Visit 4 <125 pg/mL (n = 320) | Visit 4 ≥125 pg/mL (n = 1019) | |||
Age, y | 62.6 (5.7) | 61.8 (5.4) | 64.2 (5.6) | 62.6 (5.5) | 65.3 (5.7) | <.001 |
Women, No. (%) | 5523 (56.5) | 3453 (51.6) | 1088 (62.4) | 247 (77.2) | 731 (71.7) | <.001 |
Men, No. (%) | 4253 (43.5) | 3240 (48.4) | 655 (37.6) | 73 (22.8) | 288 (28.3) | |
Black, No. (%) | 2082 (21.3) | 1606 (24.0) | 260 (14.9) | 69 (21.6) | 145 (14.2) | <.001 |
White, No. (%) | 7694 (78.7) | 5087 (76.0) | 1484 (85.1) | 251 (78.4) | 874 (85.8) | |
Hypertension, No. (%) | 4458 (45.6) | 2704 (40.4) | 991 (56.8) | 170 (53.0) | 598 (58.7) | <.001 |
Hypertension medication, No. (%) | 3353 (34.3) | 2035 (30.4) | 715 (41.0) | 142 (44.4) | 470 (46.1) | <.001 |
Blood pressure, mm Hg | ||||||
Systolic | 128.3 (20.1) | 126.4 (18.7) | 133.3 (21.8) | 126.8 (22.4) | 132.87 (22.7) | <.001 |
Diastolic | 70.0 (9.9) | 70.2 (9.6) | 70.1 (10.6) | 68.8 (10.3) | 69.0 (10.7) | .04 |
LDL-C, mg/dL | 123.0 (33.3) | 124.8 (33.0) | 118.8 (32.8) | 123.2 (33.6) | 117.7 (34.7) | <.001 |
Triglycerides, mg/dL | 62.4 (37.9) | 62.9 (38.9) | 62.4 (35.8) | 62.2 (42.1) | 59.3 (32.4) | .04 |
Cholesterol-lowering medication, No. (%) | 1339 (13.7) | 863 (12.9) | 270 (15.5) | 41 (12.9) | 167 (16.4) | .001 |
Diabetes, No. (%) | 1506 (15.4) | 1084 (16.2) | 263 (15.1) | 46 (14.5) | 114 (11.2) | .001 |
Blood glucose, mg/dL | 1980.2 (663.1) | 2012.6 (699.1) | 1922.5 (591.0) | 1958.6 (652.3) | 1873.9 (499.1) | <.001 |
Body mass indexb | 28.7 (5.5) | 28.9 (5.3) | 28.3 (5.6) | 28.8 (6.0) | 27.4 (5.8) | <.001 |
eGFR, mL/min/1.73m2 | 86.1 (16.3) | 88.5 (15.1) | 81.7 (17.1) | 83.6 (15.7) | 78.4 (18.4) | <.001 |
Current smoking, No. (%) | 1408 (14.4) | 910 (13.6) | 277 (15.9) | 60 (18.6) | 164 (16.1) | .003 |
Prevalent coronary heart disease, No. (%) | 694 (7.1) | 315 (4.7) | 188 (10.8) | 23 (7.3) | 166 (16.3) | <.001 |
Abbreviations: ARIC, Atherosclerosis Risk in Communities; eGFR, estimated glomerular filtration rate; LDL-C, low-density lipoprotein cholesterol; NT-proBNP, N-terminal pro–B-type natriuretic peptide.
SI conversion factors: To convert cholesterol to millimoles per liter, multiply by 0.0259; glucose to millimoles per liter, multiply by 0.0555; NT-proBNP to nanograms per liter, multiply by 1; triglycerides to millimoles per liter, multiply by 0.0113.
Continuous variables expressed as means (SDs) and compared using analysis of variance. Categorical variable expressed as percentages and compared using χ2 test.
Body mass index is calculated as weight in kilograms divided by height in meters squared.